Allscripts (MDRX) Tops Q3 EPS by 1c

Allscripts (NASDAQ: MDRX) reported Q3 EPS of $0.13, $0.01 better than the analyst estimate of $0.12. Revenue for the quarter came in at $355 million versus the consensus estimate of $353.68 million.

Allscripts sees FY2015 EPS of $0.45-$0.47. Allscripts sees FY2015 revenue of $1.39-1.45 billion.

For earnings history and earnings-related data on Allscripts (MDRX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Hermès can regain momentum despite China weakness, Jefferies says
• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight